Physician profile
Michael Macciocca
NPI 1700012820
$19,112.46
in general payments reported to CMS, 2019-2025
25 companies · $1,367 in 2025
The $1,367 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,193 · 2020: $1,524 · 2021: $1,532 · 2022: $2,314 · 2023: $2,245 · 2024: $1,937 · 2025: $1,367.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,549.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,548.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $4,703.58 | 2019-2020 | |
| Boston Scientific Corporation | $4,681.61 | 2019-2025 | Avvigo Guidance System, Watchman Access System, Comet |
| Medtronic, INC. | $2,528.32 | 2021-2025 | Corevalve Evolut R, Onyx Frontier, Symplicity G3 |
| Edwards Lifesciences Corporation | $1,189.81 | 2019-2025 | Pascal, Sapien 3 Ultra Resilia |
| Janssen Pharmaceuticals, INC | $1,093.08 | 2019-2024 | Xarelto |
| Abbott Laboratories | $961.40 | 2019-2025 | Cardiomems, Navitor, Mitraclip |
| Pfizer INC. | $929.52 | 2020-2025 | |
| Abiomed | $853.49 | 2019-2024 | Impella |
| W. L. Gore & Associates, INC. | $555.17 | 2019-2024 | Gore Cardioform Septal Occluder |
| E.R. Squibb & Sons, L.L.C. | $341.86 | 2020-2025 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals Lp | $278.20 | 2019-2025 | Brilinta, Lokelma |
| Impulse Dynamics (USA) INC. | $265.32 | 2023-2024 | Optimizer, Optimizer |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $169.56 | 2019-2021 | |
| Scpharmaceuticals INC. | $150.10 | 2024-2025 | |
| Angiodynamics, INC. | $119.64 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $84.98 | 2020-2024 | Acuson Origin Diagnostic Ultrasound System |
| Cardiovascular Systems INC. | $39.74 | 2020-2023 | Diamondback Coronary |
| Imperative Care, INC | $32.56 | 2025 | Symphony Catheter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.57 | 2019 | |
| Amgen INC. | $25.56 | 2019-2020 | |
| Heartflow, INC. | $20.93 | 2023 | Ffrct |
| Lexicon Pharmaceuticals, INC. | $20.40 | 2023 | Inpefa |
| Terumo Medical Corporation | $15.32 | 2022 | |
| Chiesi USA, INC. | $13.43 | 2022 | |
| United Therapeutics Corporation | $13.31 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Macciocca listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.